Table 6.
Binary logistic regression analyses of the covariates/factors associated with treatment outcome at posttreatment and follow-up for the early improvement definition after 30 days (EI30/NEI30).
| B (SE) | OR | 95% CI | P value | |
|---|---|---|---|---|
| Posttreatment | ||||
| Baseline BDI | −.12 (.02) | .89 | .86–.92 | .000 |
| Treatment duration | −.01 (.01) | .99 | .98–1.00 | .023 |
| Age | −.00 (.01) | .99 | .98–1.02 | .913 |
| EI30/NEI30 | −1.29 (.39) | .28 | .13–.59 | .001 |
| CD/NCD | .15 (.44) | 1.16 | .49–2.72 | .739 |
| Interaction EI30/NEI30 days × CD/NCD | .90 (.82) | 2.45 | .50–12.13 | .272 |
|
| ||||
| Follow-up | ||||
| Baseline BDI | −.06 (.01) | .94 | .92–.97 | .000 |
| Treatment duration | −.01 (.00) | .99 | .99–1.00 | .076 |
| Age | .01 (.01) | 1.01 | 1.00–1.03 | .148 |
| EI30/NEI30 | −.92 (.34) | .40 | .21–.78 | .007 |
| CD/NCD | .04 (.36) | 1.04 | .51–2.11 | .909 |
| Interaction EI30/NEI30 × CD/NCD | 1.18 (.69) | 3.25 | 8.34–12.67 | .089 |